Compare

Rafael Holdings, Inc. vs Shattuck Labs, Inc. vs 60 Degrees Pharmaceuticals, Inc. vs Dare Bioscience, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearRafael Holdings, Inc.
RFL
Shattuck Labs, Inc.
STTK
60 Degrees Pharmaceuticals, Inc.
SXTP
Dare Bioscience, Inc.
DARE
Year ended2026-07-312025-12-312025-12-312025-12-31
Revenue$874.0K$1.00M$1.01M$1.03M
Revenue growth (YoY)-4.7%-82.5%+65.5%n/m
Gross marginn/an/a22.3%71.3% (computed)
Operating marginn/mn/m-771.6%n/m
Net marginn/mn/m-732.5%n/m
Net income-$29.64M-$48.81M-$7.37M-$13.40M
EPS (Diluted)-$0.58-$0.70-$11.73-$1.20
Operating cash flow-$29.99M-$39.88M-$6.85M-$9.90M
Free cash flow-$29.99M-$39.95M-$6.99M-$10.29M
Cash & equivalents$22.10M$54.19M$1.51M$24.71M
Total assets$83.06M$91.03M$5.37M$32.47M
Total liabilities$11.09M$8.64M$1.99M$29.63M
Shareholders' equity$71.97M$82.39M$3.46M$2.84M
Return on year-end equity-41.2%-59.2%-212.7%-471.4%
Shares outstandingn/a63.28M1.16M14.50M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearRafael Holdings, Inc.Shattuck Labs, Inc.60 Degrees Pharmaceuticals, Inc.Dare Bioscience, Inc.
Latest$874.0K
Ended 2026-07-31
$1.00M
Ended 2025-12-31
$1.01M
Ended 2025-12-31
$1.03M
Ended 2025-12-31
1 year earlier$917.0K
Ended 2025-07-31
$5.72M
Ended 2024-12-31
$607.6K
Ended 2024-12-31
$9.8K
Ended 2024-12-31
2 years earlier$637.0K
Ended 2024-07-31
$1.66M
Ended 2023-12-31
$253.6K
Ended 2023-12-31
$2.81M
Ended 2023-12-31
3 years earlier$279.0K
Ended 2023-07-31
$652.0K
Ended 2022-12-31
$223.2K
Ended 2022-12-31
$10.00M
Ended 2022-12-31
4 years earlier$410.0K
Ended 2022-07-31
$30.02M
Ended 2021-12-31
n/a$0
Ended 2021-12-31